Curiosity Delivers.

FDA

FDA

McGill bioethicists argue for stricter limits on first-in-human clinical trials

The standards for drugs entering first-in-human (FIH) clinical trials are too low, argues Associate Professor Dr. Jonathan Kimmelman and PhD candidate Carole Federico in McGill’s Biomedical Ethics Unit. In a commentary published online in Nature on Jan. 30, Kimmelman and Federico maintain that evidence for drug efficacy is not emphasized enough before FIH trials and call for… Keep Reading

FDA

Part of Frank Dawson Adams Auditorium ceiling collapses

On Nov. 3, the ceiling of the auditorium in the Frank Dawson Adams Building leaked water and partially collapsed during a RELG 252: Hinduism and Buddhism lecture. No injuries were reported. According to Associate Director of Preventative Maintenance Claude Lahaie, the leak was a result of human error. “Because the building is very old, we… Keep Reading

FDA

Drug price hike causes global outrage

Martin Shkreli, CEO of Turing Pharmaceuticals, was harshly criticized last week after raising the cost of one of the company’s drugs, Daraprim, from $13.40 USD to $750 USD—an increase of 5,000 per cent. Manufactured exclusively by Turing, this price hike has reignited the debate on the ethics of charging patients for medicine.  Daraprim is used to… Keep Reading

Curiosity Delivers.
Go to Top